Eton Pharmaceuticals (ETON) Shares Outstanding (2019 - 2025)
Historic Shares Outstanding for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $26.8 million.
- Eton Pharmaceuticals' Shares Outstanding rose 379.83% to $26.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year increase of 379.83%. This contributed to the annual value of $26.7 million for FY2024, which is 397.47% up from last year.
- Latest data reveals that Eton Pharmaceuticals reported Shares Outstanding of $26.8 million as of Q3 2025, which was up 379.83% from $26.8 million recorded in Q2 2025.
- Eton Pharmaceuticals' 5-year Shares Outstanding high stood at $25.7 billion for Q1 2024, and its period low was $24.5 million during Q1 2021.
- Moreover, its 5-year median value for Shares Outstanding was $25.6 million (2023), whereas its average is $1.4 billion.
- As far as peak fluctuations go, Eton Pharmaceuticals' Shares Outstanding soared by 10063000.8% in 2024, and later tumbled by 9989.56% in 2025.
- Quarter analysis of 5 years shows Eton Pharmaceuticals' Shares Outstanding stood at $24.6 million in 2021, then rose by 2.95% to $25.4 million in 2022, then rose by 1.32% to $25.7 million in 2023, then rose by 3.97% to $26.7 million in 2024, then increased by 0.41% to $26.8 million in 2025.
- Its Shares Outstanding was $26.8 million in Q3 2025, compared to $26.8 million in Q2 2025 and $26.8 million in Q1 2025.